WA
Schedule 13D filing
Weiss Asset Management LP cut its Theravance Biopharma, Inc. (TBPH) stake below 5%
Weiss Asset Management LP reported owning 0% of Theravance Biopharma, Inc. (TBPH) in a Schedule 13D filed Sep 25, 2026.
A 13D means the holder may push for changes at the company.
- Disclosed
- Sep 25, 2026
- Source
- Schedule 13D
More TBPH insider and Congress trades
From a public Schedule 13D, linked above. Not investment advice, and not a recommendation to buy or sell.